Research Archive — Page 44 of 137
-
June 8, 2023
Study finds Mark Cuban’s Cost Plus Drug Company could save taxpayers millions on Medicare generic oncology drugs
Vanderbilt research finds that the U.S. government could save taxpayers between $228 million-$2.15 billion a year if insurers who operate its Medicare Part D plans purchased seven generic oncology drugs at the same prices obtained by the Mark Cuban Cost Plus Drug Company. -
June 8, 2023
Novel technology helps identify parathyroids during pediatric endocrine surgery
A Vanderbilt study found that a probe technology that uses near-infrared autofluorescent lighting helps positively identify and preserve childrens' parathyroids during endocrine surgery. -
June 8, 2023
Enhanced treatment helps fast nicotine metabolizers quit smoking
A study from Vanderbilt researchers has found that enhanced treatment support can help smokers who have more difficulty quitting because they are fast metabolizers of nicotine. -
June 1, 2023
ChatGPT tested for clinical decision support
-
May 24, 2023
Researchers probe the impact of sex and gender on human health
Vanderbilt University Medical Center's Lea Davis, PhD, and longtime colleagues Ekaterina (Katya) Khramtsova, PhD, and Barbara Stranger, PhD, are among seven authors of a paper published May 11 in the journal Cell that outlines “best practices” for evaluating the impact of both sex and gender on human health. -
May 23, 2023
Treating kidney injury before it happens
Pretreatment of an animal model with a novel compound called PHAD reduced kidney injury, suggesting it may be a good candidate for preventing kidney injury in surgical patients. -
May 22, 2023
Neurofluid flow and Alzheimer’s disease
Vanderbilt researchers used novel MRI methods to noninvasively quantify measures of neurofluid circulation and found that hypertrophy of a site of cerebrospinal fluid egress may be related to amyloid-beta retention in Alzheimer’s disease.